The "PGAP3 Gene Hyperphosphatasia with Mental Retardation Syndrome Type 4 Genetic Test" is a specialized diagnostic tool used to detect mutations in the PGAP3 gene, which are linked to Hyperphosphatasia with Mental Retardation Syndrome Type 4 (HPMRS4). HPMRS4 is a rare genetic disorder characterized by elevated levels of alkaline phosphatase in the blood, intellectual disability, and potentially other physical and neurological abnormalities. The test is crucial for confirming the diagnosis, understanding the disease's progression, and aiding in the development of a tailored management plan for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a reliable analysis of the PGAP3 gene to identify mutations responsible for the condition. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed report provided. By opting for this test, patients and their families can gain valuable insights into the genetic basis of HPMRS4, enabling better-informed decisions regarding care and support.
The "PIGW Gene Hyperphosphatasia with Mental Retardation Syndrome Type 5 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE. This test is designed to identify mutations in the PIGW gene, which are associated with Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5). HPMRS5 is a rare genetic disorder characterized by elevated levels of alkaline phosphatase, intellectual disability, and various physical and developmental anomalies. The test is crucial for the accurate diagnosis of this syndrome, allowing for better management and understanding of the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this genetic analysis. By detecting specific genetic mutations, the test provides essential information for families and healthcare providers, enabling informed decisions about care and treatment options.
The IRX5 Gene Hamamy Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the IRX5 gene, which are linked to Hamamy Syndrome. This condition, also known as Heart-Hand Syndrome, is a rare genetic disorder characterized by heart anomalies, facial dysmorphisms, and hand abnormalities. The test involves analyzing the patient's DNA to detect specific genetic alterations associated with the syndrome, providing crucial information for accurate diagnosis and management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is meticulously designed to ensure high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise involved in the testing process. By opting for this test, individuals suspected of having Hamamy Syndrome can gain valuable insights into their genetic makeup, paving the way for targeted treatments and informed healthcare decisions.
The HOXA13 gene plays a crucial role in the development of limbs and the urogenital tract. Mutations in this gene are associated with Hand-Foot-Genital (HFG) Syndrome, a rare genetic disorder characterized by limb malformations and urogenital defects. The Hand-Foot-Uterus Syndrome Genetic Test is a specific diagnostic tool designed to identify mutations in the HOXA13 gene to confirm a diagnosis of HFG Syndrome. This test is particularly vital for families with a history of the condition or when symptoms suggestive of the syndrome are present in an individual.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to search for abnormalities in the HOXA13 gene. The process is meticulous, ensuring high accuracy and reliability in the results. At a cost of 4400 AED, the test is a critical step towards a definitive diagnosis, paving the way for appropriate management and counseling for affected individuals and their families. Early diagnosis through this genetic test can significantly improve the quality of life for those with HFG Syndrome, allowing for targeted interventions and informed family planning decisions.
Hartsfield syndrome is a rare genetic disorder characterized by the combination of holoprosencephaly, a condition where the brain fails to divide properly into two hemispheres, and ectrodactyly, the absence of one or more central digits on the hands and/or feet. The FGFR1 gene, or Fibroblast Growth Factor Receptor 1 gene, plays a significant role in this syndrome. Mutations in the FGFR1 gene have been linked to various developmental disorders, including Hartsfield syndrome.
To diagnose this condition, a specific genetic test targeting the FGFR1 gene can be conducted. This test involves analyzing the patient's DNA to identify mutations in the FGFR1 gene that are known to cause Hartsfield syndrome. It's a critical step in confirming the diagnosis, understanding the condition's severity, and making informed decisions about the management and treatment of the disorder.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test for Hartsfield syndrome. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic testing, ensuring accurate and reliable results. This test is essential for families seeking answers about this rare condition, providing them with crucial information for medical and supportive care planning.
The "LMNA Gene Heart-Hand Syndrome Slovenian Type Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the LMNA gene that are associated with Heart-Hand Syndrome Slovenian Type. This condition is a rare genetic disorder characterized by a combination of heart anomalies and limb deformities. The LMNA gene plays a crucial role in the structure and function of cells in the body, and mutations in this gene can lead to various health issues, including cardiovascular diseases and skeletal abnormalities.
The test is particularly significant for individuals with a family history of the syndrome or those exhibiting symptoms, as early detection can lead to better management of the condition. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the LMNA gene.
Priced at 4400 AED, the test is conducted by DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate and reliable results. By opting for this test, patients and their families can gain valuable insights into their genetic health, enabling informed decisions regarding treatment and management strategies for Heart-Hand Syndrome Slovenian Type.
The ADNP Gene Helsmoortel-van der Aa Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the ADNP gene, which are associated with Helsmoortel-van der Aa Syndrome. This rare genetic disorder is characterized by a spectrum of symptoms including intellectual disability, autism spectrum disorder traits, distinct facial features, and potential congenital anomalies. The test plays a crucial role in the early diagnosis and management of the syndrome, enabling tailored therapeutic strategies and support for affected individuals and their families. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to ensure accurate results. By opting for this test at DNA Labs UAE, patients and healthcare providers can access critical genetic information, paving the way for improved outcomes and a better understanding of the condition.
The FAT4 gene Hennekam Lymphangiectasia-Lymphedema Syndrome Type 2 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the FAT4 gene. This gene plays a critical role in cell growth, division, and development, and mutations within it can lead to Hennekam syndrome type 2, a rare genetic disorder characterized by lymphangiectasia (dilation of the lymph vessels), lymphedema (swelling due to lymph fluid accumulation), and other developmental anomalies. The syndrome is inherited in an autosomal recessive pattern, meaning that two copies of the defective gene, one from each parent, are required for the condition to manifest.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing the genetic material for specific mutations in the FAT4 gene. It is crucial for individuals with a family history of Hennekam syndrome or those displaying symptoms suggestive of the disorder. Early diagnosis through this genetic test can lead to better management of the condition, including appropriate therapeutic interventions and surveillance for potential complications.
The cost of the FAT4 gene Hennekam Lymphangiectasia-Lymphedema Syndrome Type 2 genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the testing process and the specialized expertise required to interpret the results accurately. Individuals considering this test should consult with a healthcare provider or a genetic counselor to understand the implications of the testing fully and to ensure it is the appropriate step based on their personal and family health history.
The ZIC3 Gene Heterotaxy Visceral Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the ZIC3 gene, which are associated with Heterotaxy Visceral Type 1. Heterotaxy syndrome is a rare congenital condition characterized by the abnormal arrangement of internal organs across the left-right axis of the body, which can affect the heart, liver, lungs, and spleen. The condition can lead to significant health issues, including complex congenital heart disease and functional abnormalities of the affected organs.
The test targets individuals who exhibit symptoms of heterotaxy syndrome or have a family history of the condition, providing crucial information for diagnosis, treatment planning, and genetic counseling. By analyzing the ZIC3 gene specifically, the test can pinpoint mutations responsible for the disorder, offering insights into the genetic basis of the patient's condition.
Priced at 4400 AED, the test is conducted at the state-of-the-art facilities of DNA Labs UAE, which is known for its cutting-edge genetic testing services. The cost reflects the comprehensive nature of the test, including the sophisticated techniques used for genetic analysis, the expertise required to interpret the results accurately, and the personalized care provided to each patient.
Overall, the ZIC3 Gene Heterotaxy Visceral Type 1 Genetic Test represents a critical tool in the diagnosis and management of heterotaxy syndrome, facilitating targeted interventions and supporting affected families in understanding their genetic health landscape.
The "CFC1 Gene Heterotaxy Visceral Type 2 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the CFC1 gene, which are associated with Heterotaxy Visceral Type 2, a rare genetic disorder. This condition is characterized by the abnormal arrangement of internal organs across the left-right axis of the body, potentially affecting the heart, liver, spleen, and other organs. The test is crucial for early diagnosis and management of the disorder, offering insights into treatment options and genetic counseling for affected families.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genetic sequencing technologies to accurately detect mutations in the CFC1 gene. The process involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for the presence of genetic abnormalities linked to the condition.
The cost of the "CFC1 Gene Heterotaxy Visceral Type 2 Genetic Test" at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to perform it. For families and individuals facing the possibility of Heterotaxy Visceral Type 2, this test represents a critical step towards understanding their genetic health and making informed decisions about their care.
